THE ROLE OF THE TRANSCRIPTION FACTOR GFI1 IN LEUKEMIA GENOME STABILITY AND EVOLUTION

EHA Library, Daria Frank, 214636

VEGFC ANTIBODY TREATMENT: A NEW DIFFERENTIATION THERAPY FOR AML

EHA Library, Kim Kampen, 214637

GENE EXPRESSION PROFILING IDENTIFIES CHARACTERISTIC TRANSCRIPTIONAL SIGNATURES OF GENOMIC INSTABILITY IRRESPECTIVE OF TP53 IMPAIRMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Johannes Bloehdorn, 214639

MASS CYTOMETRY REVEALED LEUKEMIC MICROENVIRONMENT COMPLEXITY: IMPLICATIONS FOR IMMUNOTHERAPY IN A MOUSE MODEL OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Marina Wierz, 214640

FIRST-IN-CLASS ORAL TYROSINE KINASE INHIBITOR (KAN0439834) TARGETING ROR1 INDUCED SIGNIFICANT APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Mohammad Hojjat-Farsangi, 214641

GENOMIC AND CLINICAL CHARACTERIZATION OF THE ROLE OF MYD88 MUTATION STATUS IN WALDENSTROM’S MACROGLOBULINEMIA

EHA Library, Zachary Hunter, 214642

IN-SILICO DISSECTION OF DIFFUSE LARGE B CELL LYMPHOMA MICROENVIRONMENT PROVIDES A 45-GENE PANEL FOR RISK STRATIFICATION

EHA Library, Sabino Ciavarella, 214643

GENOMIC CHARACTERISATION OF CIRCULATING TUMOUR DNA (CTDNA) PREFERENTIALLY IDENTIFIES EARLY CLINICALLY RELEVANT GENOMIC EVENTS AND PROVIDES INSIGHT INTO THE CLONAL ARCHITECTURE OF LYMPHOID MALIGNANCY

EHA Library, Piers Blombery, 214644

THE DIALOG BETWEEN MANTLE CELL LYMPHOMA AND MONOCYTES/MACROPHAGES CAN BE DISRUPTED BY BTK INHIBITION AND MONITORED THROUGH CD163 MODULATION IN VIVO

EHA Library, Antonin Papin, 214645

MYD88 CONSTITUTIVE ACTIVATION IS DIRECTLY ABLE TO INDUCE INDOLENT LYMPHOPLASMACYTIC LYMPHOMA WITH MONOCLONAL IGM PEAK SECRETION IN 1 YEAR OLD MICE: A MODEL FOR WALDENSTROM'S MACROGLOBULINEMIA

EHA Library, Christelle VINCENT-FABERT, 214646

CELL OF ORIGIN AND GENOMIC PROFILE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA DETERMINED USING THE NANOSTRING LST ASSAY AND ULTRA DEEP TARGETED NEXT GENERATION SEQUENCING

EHA Library, Csaba Bödör, 214647

IMPACT OF NPM1 MRD STATUS AFTER TWO CYCLES OF INTENSIVE CHEMOTHERAPY TO INFORM TYPE OF POST-REMISSION THERAPY: A STUDY OF THE AML STUDY GROUP (AMLSG)

EHA Library, Silke Kapp-Schwoerer, 214651

DISTINCT DNA METHYLATION PROFILES IN DIFFERENT CYTOGENETIC SUBGROUPS OF CHRONIC LYMPHOCYTIC LEUKEMIA: THE INTRIGUING CASE OF TRISOMY 12

EHA Library, Maria Tsagiopoulou, 214652

BIALLELIC INACTIVATION OF ATM AND BIRC3 IN DEL(11Q) CELLS DRIVES GENOMIC INSTABILITY AND TUMOR EXPANSION IN CRISPR/CAS9-GENERATED MODELS OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Miguel Quijada-Álamo, 214653

CD20 IS A DIRECT REGULATOR OF B-CELL RECEPTOR SIGNALING IN THE MICROENVIRONMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Gabriela Pavlasova, 214654

ROLE OF MTORC1 IN NORMAL HAEMOPOIESIS AND LEUKAEMOGENESIS

EHA Library, Natasha Malik, 214655

IDENTIFICATION OF A MIR-146B-FASL AXIS IN THE DEVELOPMENT OF NEUTROPENIA IN T-LARGE GRANULAR LYMPHOCYTES LEUKEMIA

EHA Library, Giulia Calabretto, 214656

INFLAMED BM-MSCS HIGHLY ATTRACT TEL-AML1+ PRE-LEUKEMIC CELLS AND PROVIDE A SUSTAINING NICHE FOR THEIR EMERGENCE

EHA Library, Linda Beneforti, 215233

TRANSLATOME ANALYSIS REVEALS ALTERED SERINE METABOLISM IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Kim Kampen, 215234

TITLE: PROGNOSTIC IMPACT OF THE BCR/ABL1-LIKE SIGNATURE IN ADULT B-LINEAGE ALL. FIRST ANALYSIS OF THE GIMEMA LAL1913 PROTOCOL

EHA Library, Sabina Chiaretti, 215235

CHARACTERIZATION OF PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH DNA METHYLATION STATUS

EHA Library, Shunsuke Kimura, 215236

THE PHILADELPHIA-LIKE SUBTYPE IN CHILDREN WITH FIRST RELAPSE OF B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A STUDY OF THE GERMAN ALL-REZ BFM 2002 TRIAL

EHA Library, Malwine Pogodzinski, 215237

HUMAN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA DEVELOPS HYPOXIA-RELATED CHEMORESISTANCE THROUGH HIF1Α AND MTOR PATHWAY INTERACTIONS

EHA Library, Lucine Fahy, 215238

CLONAL EVOLUTION OF ACUTE LYMPHOBLASTIC LEUKEMIA CELLS FROM DIAGNOSIS TO RELAPSE

EHA Library, shumaila sayyab, 215239

REFINED DETECTION AND PHASING OF STRUCTURAL ABERRATIONS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH LINKED-READ WHOLE GENOME SEQUENCING

EHA Library, Yanara Marincevic-Zuniga, 215240

AMPLICON-BASED NGS AS A TOOL FOR THE IDENTIFICATION OF NEW MARKERS WITH POOR PROGNOSIS IN B-ALL

EHA Library, Adrián Montaño, 215241

EXPLORING THE GENOMIC DIVERSITY OF AYA AND ADULT HIGH-RISK B-ALL CASES BY MRNA SEQUENCING

EHA Library, Susan Heatley, 215242

FUNCTIONAL CHARACTERIZATION OF ABERRANT FAT1 EXPRESSION IN T-ALL

EHA Library, Sven Liebig, 215243

“TRIPLE NEGATIVE” ACUTE GENE EXPRESSION CLUSTERING IDENTIFY NEW ADULT LYMPHOBLASTIC LEUKEMIA SUBGROUPS

EHA Library, Anna Ferrari, 215244

MOLECULAR PROFILE REFINES THE MRD-BASED PROGNOSTIC ASSESSMENT IN ADULTS WITH PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jordi Ribera, 215245

TCR ALPHA GENE REARRANGEMENTS AS A NEW TYPE OF CLONAL MARKERS IN PEDIATRIC T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alexander Komkov, 215246

COHESIN GENES MUTATIONS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Grazia Fazio, 215248

EVALUATION OF SAMPLE QUALITY AND CREATION OF DATABASES FOR FOLLOW-UP ASSESSMENT OF BLAST INFILTRATION AT DAY +15 IN CHILDHOOD B CELL ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Pablo Manresa Manresa, 215249

GENETIC ALTERATIONS OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN TAIWAN: A COMPARISON BETWEEN PEDIATRIC AND ADULT COHORTS

EHA Library, Ying-Jung Huang, 215250

FIRST RESULTS OF NEW GIMEMA TRIAL LAL1913 FOR ADULT PATIENTS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH- ALL)

EHA Library, Renato Bassan, 215251

LOW MIR-151 AND MIR-451 LEVELS IN BONE MARROW AT DIAGNOSIS IS CONFIRMED AS A PROGNOSTIC FACTOR FOR RELAPSE OF B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM THE AIEOP 2000 CLINICAL TRIAL

EHA Library, Jennifer Yarden, 215252

THE CELL SURFACE PROTEIN VANIN-2 IDENTIFIES AGGRESSIVE SUBTYPES OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Virginia Rodriguez Martinez, 215253

NILOTINIB COMBINED WITH LOWER-INTENSITY CHEMOTHERAPY FOR FRONT-LINE TREATMENT OF YOUNGER ADULTS WITH PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): INTERIM ANALYSIS OF THE GRAAPH-2014 TRIAL

EHA Library, Yves Chalandon, 215254

PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA AND MLL REARRANGEMENT SHOW A DISTINCTIVE EXPRESSION PATTERN OF HISTONE DEACETYLASES

EHA Library, Nerea Vega-Garcia, 215255

PROTEOLYTIC L-ASPARAGINASE DEGRADATION AS A MECHANISM FOR NON-ANTIBODY-RELATED DRUG INACTIVATION

EHA Library, Justyna Walenciak, 215256

EXTRAMEDULLARY LATE RELAPSES IN ATYPICAL SITES OF ACUTE LYMPHOBLASTIC LEUKEMIA: A RETROSPECTIVE STUDY OF THE ITALIAN ASSOCIATION OF PEDIATRIC HEMATOLOGY AND ONCOLOGY (AIEOP)

EHA Library, Giovanna Giagnuolo, 215257

INCIDENCE AND OUTCOME OF RELAPSES IN YOUNG ADULTS (18-60 YR) WITH PH--POSITIVE ALLTREATED WITH IMATINIB, CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (PETHEMA ALLPH08 TRIAL)

EHA Library, Josep Maria Ribera, 215258

VENETOCLAX AND NAVITOCLAX WITH CHEMOTHERAPY IS EFFICACIOUS IN PATIENTS WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Thomas Alexander, 215259

IDENTIFICATION OF BCR-ABL-LIKE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY REAL-TIME PCR

EHA Library, Grigory Tsaur, 215260

DELIVERY OF INTRATHECAL METHOTREXATE CHEMOPROPHYLAXIS TO ADULTS AND TYA PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA – AN AUDIT OF FACTORS AFFECTING PROTOCOL ADHERENCE

EHA Library, Sven Armin Sommerfeld, 215261

THE PROGNOSIS FOR PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WHO WERE INELIGIBLE FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN THE TKI ERA.

EHA Library, Akio Shigematsu, 215262

ENHANCING MANAGEMENT OF PH+ ALL BY MONITORING WITH AN ANALYTICALLY VALIDATED MULTIPLEX ASSAY FOR BCR-ABL1 MINOR BREAKPOINT (E1A2) WITH HIGHLY SENSITIVE DETECTION OF 1:40,000 (0.0025% OR 4.6 LOGS)

EHA Library, Justin Brown, 215264

THE RISK OF DEVELOPING HEPATIC TOXICITY FROM PEGYLATED-ASPARAGINASE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IS HIGHLY AFFECTED BY CONCOMITANT MEDICATIONS

EHA Library, Paola Minetto, 215265

CELL OF ORIGIN INFLUENCES DISEASE AGGRESSIVENESS AND CHEMOTHERAPY RESISTANCE IN A MOUSE MODEL OF MLL-AF9 REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Chi Nguyen, 215266

PLASMA PROTEOME IN PATIENTS WITH LEUKEMIA AND LYMPHOMA REVEALS MAJOR DIFFERENCES RELATED TO HEMOSTASIS, INFLAMMATION AND STROMA

EHA Library, Anna Eriksson, 215267

IDENTIFICATION OF CALM/AF10 (PICALM/MLLT10) COOPERATING MUTATIONS IN A ZEBRAFISH LEUKAEMIA MODEL

EHA Library, Omid Delfi, 215268

FLT3-ITD ANALYSIS ON RNA CONFERS ENHANCED SENSITIVITY AND ALLOWS EARLIER RELAPSE PREDICTION

EHA Library, Elisabeth Oppliger Leibundgut, 215269

PHARMACOLOGIC INHIBITION OF CELLULAR METABOLIC PROCESSES IMPACTED BY AGING SENSITIZE ACUTE MYELOID LEUKEMIA (AML) CELLS TO THE NOVEL LIPOATE DERIVATIVE CPI-613

EHA Library, Timothy Pardee, 215270

GENOMIC CHARACTERIZATION OF DIAGNOSTIC AND REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA SAMPLES THROUGH A NEXT GENERATION SEQUENCING (NGS) PANEL OF 62 GENES

EHA Library, Diego Carbonell, 215271

HEMATOPOIETIC FUNCTIONS OF R396Q AND R204X GATA2 MUTANTS SUGGEST DISTINCT MECHANISMS LEADING TO THE GATA2 SYNDROME

EHA Library, Eric DELABESSE, 215272

SYNERGISTIC INHIBITORY EFFECT OF HYDROXYUREA AND DECITABINE ON THE PROLIFERATION OF AML CELLS

EHA Library, Konstantin Byrgazov, 215273

MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA USING MULTIPARAMETRIC FLOW CYTOMETRY IS HIGHLY PREDICTIVE OF OUTCOME

EHA Library, Chinmayee Kakirde, 215274

EXPRESSION OF CD25 FLUCTUATES IN THE LEUKEMIC STEM CELL POPULATION OF CD25-POSITIVE AML

EHA Library, Yuki Kageyama, 215275

INTEGRIN ALPHA 7 EXPRESSION IS ASSOCIATED WITH PHENOTYPE AND GROWTH OF ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Nobuhiko Kobayashi, 215276

THE ROLE OF STAT3Β IN ACUTE MYELOID LEUKEMIA

EHA Library, Petra Aigner, 215277

DISSECTING INTRA-TUMOR HETEROGENEITY IN ACUTE MYELOID LEUKEMIA THROUGH LEUKEMIA STEM CELL-ASSOCIATED MIRNA SIGNATURES AND SINGLE-CELL RNA TRANSCRIPTIONAL PROFILING

EHA Library, Matteo Maria Naldini, 215278

CLINICAL AND BIOLOGICAL CHARACTERISTICS OF TWO DISTINCT T(16;21) FUSIONS IN PEDIATRIC ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS BY THE I-BFM STUDY GROUP

EHA Library, Sanne Noort, 215279

NUP98-KDM5A FUSION GENE IS AN INDEPENDENT PREDICTOR OF POOR PROGNOSIS WITH A DISTINCT HOX GENE EXPRESSION PATTERN

EHA Library, Sanne Noort, 215280

TARGETED THERAPY FOR AML EXPRESSING SOMATIC OR GERMLINE MUTATION IN RUNX1

EHA Library, Kapil Bhalla, 215281

DECIPHERING THE GENETIC LANDSCAPE OF ACUTE MYELOID LEUKEMIA WITH COMPLEX KARYOTYPE BY TRANSCRIPTOME ANALYSIS USING RNA SEQUENCING

EHA Library, Frank Rücker, 215282

PHOSPHO-PROFILING LINKING AML-BIOLOGY AND RESPONSE PREDICTION IN PEDIATRIC MYELOID LEUKEMIA

EHA Library, Michaela Prchal-Murphy, 215283

TOWARDS IMPROVING OF SURVIVAL IN AML BY REPURPOSING EXISTING DRUGS AS NOVEL SAMHD1 INHIBITORS

EHA Library, Nikolaos Tsesmetzis, 215284

GENOMIC-DRIVEN AND FUNCTIONAL ALTERATIONS IN ENERGY, AMINO ACID AND LIPID METABOLISM IN ACUTE MYELOID LEUKEMIA BLASTS AND STEM PROGENITOR CELLS

EHA Library, Giorgia Simonetti, 215285

THE CALCIUM BINDING PROTEIN S100A8/S100A9 COMPLEX IS ASSOCIATED WITH DRUG RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Riikka Karjalainen, 215286

A HIGH RISK PEDIATRIC AML SUBTYPE PRESENTS A DIAGNOSTIC CHALLENGE-A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP AAML0531 STUDY

EHA Library, Timothy P Singleton, 215288

TARGETED COMBINATION THERAPY AGAINST ONCOGENIC PI3K/AKT/MTOR AND NFKB SIGNALLING PATHWAYS USING ACUTE MYELOID LEUKEMIA AS A CANCER MODEL

EHA Library, Montserrat Estruch Alrich, 215289

IDENTIFICATION OF GENE COPY NUMBER ABERRATIONS AS PROGNOSTIC MARKERS OF SURVIVAL IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS BY EXOME SEQUENCING OF LEUKEMIA DNA IN THE MAYO CLINIC AML EPIDEMIOLOGY COHORT

EHA Library, Yan Asmann, 215290

NEO2734, A NOVEL HIGHLY POTENT ORAL DUAL BET AND P300/CBP BROMODOMAIN INHIBITOR FOR TREATMENT OF HEMATOLGICAL MALIGNANCIES

EHA Library, Bill Brown, 215291

ACUTE MYELOID LEUKEMIA INDUCED TRANSFORMATION OF THE HUMAN BONE MARROW MICROENVIRONMENT PREDICTS CLINICAL OUTCOME

EHA Library, Yiyang Chen, 215292

IMMUNOPHENOTYPIC PROFILING OF LEUKEMIC STEM CELLS TO TRACK FLT3-ITD POSITIVE, CHEMO-RESISTANT CLONES IN ACUTE MYELOID LEUKEMIA

EHA Library, Tiziana Ottone, 215293

ASSESSMENT OF HIGH-RISK MOLECULAR MARKERS IN INTERMEDIATE RISK ACUTE MYELOID LEUKEMIA AS DEFINED BY 2010 ELN RISK CLASSIFICATION

EHA Library, Ekaterina Panina, 215294

MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)

EHA Library, Orietta Spinelli, 215295

SINGLE CELL SIGNALING PHARMACODYNAMICS AND CLONAL EVOLUTION IN A PHASE 1/2 CLINICAL TRIAL OF SELECTIVE AXL INHIBITOR BEMCENTINIB (BGB324) IN R/R ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Monica Hellesøy, 215296

FURTHER EVIDENCE FOR GPR56, BUT NOT CLL-1 (CLEC12A) AS A MARKER FOR LEUKEMIC STEM CELLS IN CD34-POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Albert Wölfler, 215297

MOLECULAR ABNORMALITIES IN THERAPY-RELATED ACUTE MYELOID LEUKEMIAS

EHA Library, Gueorgui Balatzenko, 215298

CD123 REDIRECTED NK92 CELLS FOR ACUTE MYELOID LEUKEMIA

EHA Library, Li Zhou, 215299

THE DIFFERENTIAL EXPRESSION OF DNMT3A SPLICE VARIANTS AND THEIR PROGNOSTIC RELEVANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Stefanie Beinicke, 215300

P53(D281G) MUTATION CAUSES CYTARABINE RESISTANCE VIA PROMOTING WARBURG EFFECT IN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Kit Man Ng, 215301

EVALUATION OF THE DRUG INTERACTION POTENTIAL OF PRACINOSTAT, A NOVEL HISTONE DEACETYLASE (HDAC) INHIBITOR, WITH CYP1A2 INDUCER CIGARETTE SMOKING AND CIPROFLOXACIN, A CYP1A2 INHIBITOR

EHA Library, Alberto Bernareggi, 215302

SINGLE CENTRE REAL-LIFE EXPERIENCE OF HYPOMETHYLATING AGENTS WITH OR WITHOUT DLI AS SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Davide Lazzarotto, 215303

CONSOLIDATION CHEMOTHERAPY PREVENTS RELAPSE BY INDIRECTLY REGULATING BONE MARROW ADIPOGENESIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Hanyan Liu, 215304

CONTINUING ENASIDENIB TREATMENT FOR PATIENTS WITH MUTANT-IDH2 RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) WITH STABLE DISEASE MAY RESULT IN IMPROVED RESPONSES AND SURVIVAL OVER TIME

EHA Library, Eytan M. Stein, 215305

PH II TRIAL WITH SELECTIVE ORAL AXL INHIBITOR BEMCENTINIB (BGB324) IN RELAPSED/REFRACTORY AML AND MDS: IDENTIFICATION OF PREDICTIVE AND PHARMACODYNAMIC BIOMARKER CANDIDATES ASSOCIATED WITH PT BENEFIT

EHA Library, Julia Schoelermann, 215306

CYTOGENETIC AND MOLECULAR DRIVERS OF OUTCOME WITH VENETOCLAX-BASED COMBINATION THERAPIES IN TREATMENT-NAÏVE ELDERLY PATIENTS WITH AML

EHA Library, Stephen Strickland, 215307

RANDOMIZED OPEN-LABEL, PHASE III MULTICENTER TRIAL TO EVALUATE AZACITIDINE POST-REMISSION THERAPY IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Esther N. Oliva, 215308

A PHASE 2B OF ERYASPASE IN COMBINATION WITH LOW-DOSE CYTARABINE AS FIRST-LINE THERAPY IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (ENFORCE - NCT01810705)

EHA Library, X. Thomas, 215309

AN EVALUATION OF CONTROL REGIMENS IN A GROUP OF HIGH RISK OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA FROM TWO COOPERATIVE GROUPS: DATA FROM THE UK NCRI AND DUTCH HOVON STUDIES

EHA Library, Robert Hills, 215310

TP53 ALTERATIONS AND MONOSOMAL KARYOTYPE IN OLDER UNFIT PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH DECITABINE

EHA Library, Heiko Becker, 215311

IDENTIFYING A GENETICALLY DEFINED RISK GROUP OF PEDIATRIC AML PATIENTS THAT CANNOT BE RESCUED AT ALL AFTER THE FAILURE OF THE FIRST LINE TREATMENT

EHA Library, Naghmeh Niktoreh Mofrad, 215312

A PHASE II STUDY OF THE AURORA A KINASE INHIBITOR ALISERTIB COMBINED WITH 7+3 INDUCTION CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA

EHA Library, Amir Fathi, 215313

ADMINISTRATION OF BPX-501 CELLS FOLLOWING ALPHA/BETA T-CELL AND B-CELL-DEPLETED HLA HAPLOIDENTICAL HSCT (HAPLO-HSCT) IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Neena Kapoor, 215314

COMPARISON BETWEEN MULTIPARAMETRIC FLOW CYTOMETRY AND RT-QPCR ASSAY IN EVALUATING MINIMAL RESIDUAL DISEASE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IN NPM1 ACUTE MYELOID LEUKEMIA

EHA Library, Chiara Caprioli, 215315

MRD STATUS AT TRANSPLANTATION IN SECOND OR THIRD CR IS THE STRONGEST FACTOR AFFECTING THE PROBABILITY OF RELAPSE IN AML PATIENTS

EHA Library, Fabio Guolo, 215316

THE CXCR4 INHIBITOR BL-8040 IN COMBINATION WITH CYTARABINE RESULTS IN A SIGNIFICANTLY EXTENDED OVERALL SURVIVAL OF RELAPSED/REFRACTORY AML PATIENTS

EHA Library, Gautam Borthakur, 215317

CELL-FREE DNA MONITORING OF MINIMAL RESIDUAL DISEASE IN AML USING A TARGETED NGS GENE PANEL

EHA Library, Zhiyi Xie, 215318